Recruiting Heart Attack Studies in Beijing
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question th...
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lo...
About Heart Attack Clinical Trials in Beijing
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Beijing, BEIJING%20MUNICIPALITY. These studies are seeking a combined 1,004 participants. Research is being sponsored by Corxel Pharmaceuticals, Alebund Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Beijing — FAQ
Are there heart attack clinical trials in Beijing?
Yes, there are 2 heart attack clinical trials currently recruiting in Beijing, BEIJING%20MUNICIPALITY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Beijing?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beijing research site will contact you about next steps.
Are clinical trials in Beijing free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beijing studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Beijing are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov